Top Markets
Coin of the day
ProUroCare Medical Inc. ProUroCare Medical Inc.

ProUroCare Medical Inc.

PUMD
Rank in Stocks #42361
ProUroCare Medical Inc. is dedicated to developing advanced products for the... ProUroCare Medical Inc. is dedicated to developing advanced products for the accurate identification and detailed assessment of male prostate diseases. The company's primary offering is the ProUroScan System, an innovative prostate imaging solution. This system empowers physicians to precisely document prostate irregularities that have been initially discovered through a digital rectal examination. ProUroCare has entered into strategic agreements with Artann Laboratories Inc., covering the licensing, ongoing development, and market commercialization of its ProUroScan System. The company was established in 1999 and is headquartered in Eden Prairie, Minnesota.
Share Price
$0.0001
Last synced: 2026-08-11
Market Cap
$1.86K
Change (1 day)
0.00%
Change (1 year)
-50.00%
Country
US
Trade ProUroCare Medical Inc. (PUMD)

Category

Number of shares outstanding for ProUroCare Medical Inc. (PUMD)
Number of shares outstanding as of August 2026: 0
According to ProUroCare Medical Inc. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for ProUroCare Medical Inc. (PUMD) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
1.74B -
US
383.50M -
US
1.28B -
IE
1.48B -
US
576.40M -
US